OptiBiotix interims chart a period of significant commercial progress
Product launches and sales agreements have provided the business with traction
Company
LON:OPTI
OptiBiotix Health Plc is a life sciences company operating in one of the most progressive areas of biotechnological research. Developing and commercialising technologies that modulate the human microbiome – the collective genome of the microbes in the body – the company identifies and develops prebiotic formulations and compounds for use in food ingredients and supplements that can impact on human physiology and metabolism, deriving potential health benefits.
574 stories · page 5 of 6
Product launches and sales agreements have provided the business with traction
Investments and investor services
London's FTSE 100 was trading steadily in Wednesday afternoon's exchanges.
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
OptiBiotix said this was the “first of a number of steps” being taken to build the profile of LPLDL cholesterol-reducing strain in the US
The FTSE 100 was its gains eroded as the Jackson Hole chinwag got under way
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
It is broadening its European tie-up with Italian food company Sacco, signed in March, to cover the US and rest of the world
The FTSE 100 rose 63 points to 7,382 and the pound has slipped amid Brexit fears
Archive
Some of today's headlines on the Proactive newswire
We hope this will be the first of many product launches of multiple formulations and presentations of LP-LDL as the active component in a wide range of pharmaceutical and consumer products around the world - chief executive Stephen O’Hara
Archive
A glance at some of the stories on the Proactive newswire today...
Investments and investor services
Companies covered: Andalas Power, Kennedy Ventures, Mayan Energy, Image Scan, Grand Group Investment, KEFI Minerals, Gaming Realms, Proxama, Zinc Media
OptiBiotix will develop and supply multiple consumer products containing LPldl to Pharmabiota to be sold through the latter's extensive antipodean partner network
Archive
A glance at some of the stories on the Proactive newswire today...
Investments and investor services
Shares featured: Jangada, Ilika, Carillion, Matomy Media, Bagir Group, Abzena, Bango, Galliford Try, Highlands Natural Resources
SweetBiotix is made up of sweet natural healthy fibres which aren’t digested and, as a result, are calorie-free
The market chose to interpret Broadbent's comments as a vote for the status quo
Archive
A glance at some of the small cap stories on Proactive Investors today
Risers and fallers: DFS, Next, ANGLE boosted by Barts research, Starcom wins container order, Sprue Aegis delivers bullish AGM
House broker finnCap believes HLH experienced interest in the product above the levels it had been expecting
FTSE 100 closed down 55 at 7,419 as retail shares took a beating
Archive
A glance at some of the small cap stories on the Proactive newswire today
A look at some of the biggest London-listed risers and fallers today
The company launched its SlimBiome, CholBiome and CardioBiome technologies at a tradeshow in Geneva last week
The FTSE 100 index closed up 68.94 points at 7,523 - a new record high
The non-exclusive agreement will see Italy-based Nutrilinea produce and commercialise products containing OptiBiotix’s LPLDL strain
Archive
A snapshot of the small cap news today on the Proactive newswire
Shares in InnovaDerma and Porta Communications have advanced while shares in Audioboom and Nyota Minerals have fallen
IPC2017 is the largest scientific conference worldwide focusing on probiotics and prebiotics
The FTSE 100 closed 15.52 down at 7,234 with Sainsbury's and mining shares under pressure
Archive
A glance at some of the stories on the Proactive newswire today
"We are pleased to announce the supply of LPLDL to HLH which will be sold as part of its market leading Lactobact brand," said OptiBiotix's boss, Stephen O'Hara
A look at the biggest London-listed risers and fallers today
The company said it made significant progress last year, with early revenues and a promising development pipeline.
The FTSE 100 closed 10.96 up at 7,275 but Whitbread shares slumped
Archive
Strong performances in its Costa Coffee and Premier Inn chains are expected to have helped to offset softer trading in Whitbread’s restaurant arm
Stephen O’Hara created Opti as a company all by himself in 2012 as a business focused on the rapidly growing microbiome space, which harnesses the positive benefits of microbes that live on the human body
Archive
A glance at some of the stories on the Proactive newswire today
“We are creating sugars that act as fibres, but have no calories and don’t add to obesity.”
OptiBiotix is seeking an AIM listing for its SkinBioTherapeutics subsidiary
Per Rehné and Christina Wood have now officially joined the board
The deal is with Sacco, one of Europe’s leading probiotic manufacturers and raw ingredients suppliers.
Some the largest rises and fall at 3pm: ValiRx, Faron, Jersey Oil
The Vitafoods Europe Trade Show is viewed as one of the world's leading trade fairs for the food and drinks industry.
FTSE 100 stocks, just like Wall Street, defied soothsayers’ prognoses that investors didn’t much like a threadbare speech to Congress from US President Donald Trump overnight, and pledged their vote to his spending ambitions as record heigh
Archive
A glance at some of the stories on the Proactive newswire today.
The City broker says OptiBiotix is “well-positioned” to be a leader in the growing microbiome space
Archive
Angus Energy advances Brockham well near Gatwick Gusher; Deltex Medical sees probe revenue rise again; Anglo Pacific has best year since 2011 as coal price surges; plus much more
Christina Wood will join the board in due course subject to the necessary due diligence
Archive
A glance at some of the stories on the Proactive newswire today.
The two abstracts to be presented relate to OptiBiotix’s work on its cholesterol lowering probiotic
A new study has found that the kind of bacteria you have in your gut will impact your attempts to lose weight
Archive
A glance at some of the stories on the Proactive newswire today
Per Rehné has worked for some of the world's leading food companies, including Danisco, Frutarom Nordic and Innotaste Nordic
Archive
A glance at some of the stories on the Proactive newswire today
OptiBiotix Health has kicked off the New Year by increasing its investment in subsidiary The Health Weight Loss Company Limited (THWLC)
Archive
A glance at today's headlines on the Proactive newswire ...
The two parties will work together to develop foods and over-the-counter products which contain OptiBiotix’s SlimBiome technology
It believes the progress it is making in the lab will help it to convert commercial interest into commercial deals
Microbiome research will have a seismic impact on healthcare in the coming year claims a panel of experts
Optibiotix says it has a range of product formulations, and a supporting distribution and sales structure
The cash, from a convertible loan, will provide funding to complete human studies for a first product application as well as to finance an IPO ( Initial Public Offering).
The difference between a Skinny Tan and a tinnie scan is explained.
The company is bringing on board a new chairman for SkinBiotix as it presses ahead with plans to seek an initial public offering
Followers of the AIM-listed healthcare business will have had more than a weather eye on Chr. Hansen’s £62mln takeover of a private firm called Valio.
Optibiotix releases the results of a consumer survey, Aureus Mining will become the owner and operator of its New Liberty gold mine in Liberia and Forbidden Technologies pushed up total sales by a quarter in its latest half year.
Every consumer responding to the survey said that they had lost weight over a continued period whilst using GoFigure - as they ate smaller portions and snacked less.
OptiBiotix reports strong progress, Bushveld confirms closing of a share placing and Challenger Acquisitions has had a court case against it has been dismissed.
Biggest share price risers and fallers in London at 12.30pm
The life sciences firm developing products to tackle obesity, high cholesterol and diabetes saw its IP portfolio grow signficiantly
Investors will want to see signs that an anticipated pick up in growth will materialise in the second.
Approvals remained ahead of last year in the run-up to the EU membership referendum but what about after it?
The government's childhood obesity strategy comes under fire from health campaigners. Also covered: A level results; retail sales; sterling; Amur; Concepta
Altitude Group hit the heights as its chairman bought 135,000 shares
Diamondcorp raises production in South Africa, Range Resources confirmed the spudding of its latest well in Trinidad and Utilitywise gets a new chief executive.
GoFigure products will initially be stocked in eight UK Whole Foods Market shops with opportunities for further expansion.
OptiBiotix Health appoints director of business, African Potash signs a deal with a distributor in Zambia and Proton Power Systems unveils a business overhaul.
Gosalbez may take on a board position within OptiBiotix's divisional structure as these develop into separate legal entities
Cello reports "noticeable impact" from Brexit, Tern reports a big jump in total assets, and Green Dragon has a production boost in China.
Carpet seller Victoria's results caught the eye, with revenue and adjusted EBITDA double what they were in the previous year
The JV will be used as an “incubator” for the technology to develop other functional foods that help tackle obesity.
Archive
The filing is for a combination of OptiBiotix's Lactobacillus plantarum strain
OptiBiotix is to create four separate operating divisions; Tavistock enjoyed a strong set of results; AdEPT recorded its 13th consecutive year of increased underlying earnings; and more…
OptiBiotix is about to enter a new growth phase, forming four divisions devoted to separate IP platforms
Treasury minister Jim O’Neill is proposing to tax big pharma to pay for much-needed R&D on the next generation of antibiotics.
Amur Minerals has pitched the potential of its Kun-Manie nickel project in Far East Russia to potential investors in Korea.
Pharma company shares rise as report urges action to develop super-bug treatments
Not content with fighting the modern day killers such as diabetes and obesity, OptiBiotix is aiming to tackle infections such as MRSA. And today it has filed for patents covering its new skin care technology.
The study of microbiomes is a hot area at the moment, and the US is ploughing US$500mln into research
Life sciences group OptiBiotix Health PLC has the platforms and partners in place to bring its products to market, reckons broker Hybridan. It has raised its value per share on the firm to 106p from a current price of around 81p.
Archive
Connemara Mining Company had more good news, Eland Oil & Gas Plc expects to complete flow testing and Fastjet halted its application for an air operator’s licence.
FTSE AIM All-share added 0.19% to 732.6, while FTSE100 was three points better at 6,367, another new high for the year.